| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113883.3.464.1003.110.12.1031 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031 |
| version | 20170504 |
| status | active |
| publisher | NCQA PHEMUR |
| name | MeaslesMumpsAndRubellaMMRVaccineAdministered |
| title | Measles, Mumps and Rubella (MMR) Vaccine Administered |
| date | 2022-03-03T18:46:01-05:00 |
| experimental | false |
| Usages | (none) |
This value set contains 11 concepts
| Code | System | Display |
| 170431005 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 170432003 | http://snomed.info/sct | Administration of pre-school booster dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 170433008 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 38598009 | http://snomed.info/sct | Administration of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 432636005 | http://snomed.info/sct | Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 433733003 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 571591000119106 | http://snomed.info/sct | Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 572511000119105 | http://snomed.info/sct | Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure) |
| 871909005 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
| 90707 | http://www.ama-assn.org/go/cpt | Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use |
| 90710 | http://www.ama-assn.org/go/cpt | Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use |
Produced 08 Sep 2023